M
Manpreet Dhaliwal
Researcher at Post Graduate Institute of Medical Education and Research
Publications - 17
Citations - 474
Manpreet Dhaliwal is an academic researcher from Post Graduate Institute of Medical Education and Research. The author has contributed to research in topics: Medicine & Immunology. The author has an hindex of 7, co-authored 9 publications receiving 222 citations.
Papers
More filters
Journal ArticleDOI
Epidemiology of Mucormycosis in India
TL;DR: The spectrum of etiological agents causing mucormycosis is unique as Apophysomyces elegans is the second most common pathogen after Rhizopus oryzae and many new agents are identified causing the disease.
Journal ArticleDOI
Colletotrichum truncatum: an unusual pathogen causing mycotic keratitis and endophthalmitis.
M. R. Shivaprakash,Suma B Appannanavar,Manpreet Dhaliwal,Amit Gupta,Sunita Gupta,Amod Gupta,Arunaloke Chakrabarti +6 more
TL;DR: The present series highlights the expanding spectrum of agents causing eye infections and the inclusion of C. truncatum as a human pathogen.
Journal ArticleDOI
Epidemiological study of a large cluster of fungaemia cases due to Kodamaea ohmeri in an Indian tertiary care centre.
Arunaloke Chakrabarti,S.M. Rudramurthy,P. Kale,P. Hariprasath,Manpreet Dhaliwal,Sunit Singhi,K. L. N. Rao +6 more
TL;DR: The present study reports the largest cluster of K. ohmeri fungaemia from a single centre and stresses the need for accurate identification of clinical yeast isolates.
Journal ArticleDOI
Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis.
Shivaprakash M Rudramurthy,Seyedmojtaba Seyedmousavi,Manpreet Dhaliwal,Arunaloke Chakrabarti,Jacques F. Meis,Johan W. Mouton +5 more
TL;DR: It is concluded that the efficacy of voriconazole depended on drug exposure and the vorIconazole MIC of the isolates, but lower exposures are required for strains with higher MICs, and may have profound significance in clinical practice with respect to dosing and drug choice.
Journal ArticleDOI
In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris
Shivaprakash M Rudramurthy,Thomas Colley,Alireza Abdolrasouli,Alireza Abdolrasouli,Jed Ashman,Manpreet Dhaliwal,Harsimran Kaur,Darius Armstrong-James,Pete Strong,Garth Rapeport,Silke Schelenz,Kazuhiro Ito,Arunaloke Chakrabarti +12 more
TL;DR: PC945 was found to be a more potent inhibitor than posaconazole, voriconazole and fluconazole of C. auris isolates collected globally, warranting further laboratory and clinical evaluations.